Skip to main content
. 2011 Dec 1;16(12):1729–1740. doi: 10.1634/theoncologist.2011-0163

Figure 1.

Figure 1.

Defining mechanism-based toxicity. Toxicities attributable to the mechanism of action of molecular targeted agents represent on-target modulation in normal tissues. These mechanism-based toxicities can be correlated with clinical benefit when the drug has high selectivity and adequate potency to hit the target and the tumor is addicted to the inhibited pathway.